Cart summary

You have no items in your shopping cart.

HLM006474

SKU: orb1308227

Description

HLM006474 is a pan-E2F inhibitor that blocks the DNA-binding activity of E2F transcription factors, such as E2F4, with an IC50 of 29.8 μM in A375 melanoma cells. This small molecule is a useful research tool for studying cell cycle regulation, proliferation, and oncogenic signaling pathways in various in vitro cancer models.

Research Area

Cell Biology

Images & Validation

Key Properties

CAS Number353519-63-8
MW399.48
Purity99.20%
FormulaC25H25N3O2
SMILESCCOc1ccc(cc1C)C(Nc1ccccn1)c1ccc2ccc(C)nc2c1O
TargetOthers,Early 2 Factor (E2F)
SolubilityDMSO:15.625 mg/mL (39.11 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (2.5 mM)

Bioactivity

Target IC50
E2F4 DNA-binding:29.8 μM
In Vitro
HLM006474 causes the viability of both SCLC and NSCLC lines (IC50 ranging from 15 to 75 μM). HLM006474 displays little activities against E2F4 DNA-binding in A375 cells at 10 and 20 μM, apparently inhibits E2F4 DNA-binding at 40 μM, and increasingly suppresses the effect at 60 and 80 μM concentrations. HLM006474 dramatically causes cyclin D3 protein expression and is a potent inducer of PARP cleavage. HLM006474 (20 μM) weakly synergizes with paclitaxel, but there is antagonism between HLM006474 and cisplatin and gemcitabine in H1299 cells. HLM006474 (40 μM) inhibits E2F4 activity via suppression of its DNA-binding activity and down regulation of its expression and HLM006474 (40 μM) also obviously causes apoptosis in A375 and 231 cell lines for 24 hours. HLM006474 (60 μM) enhances the expression of several known E2F-regulated genes after short treatments in H292 and H1299 cell lines. HLM006474 leads to a reduction in the mRNA levels of MAD2. HLM006474 apparently suppresses the increase of Mad2 protein and pRb-S780 signal but not the level of Skp2 protein in human lung cancer A549 cellss.

Storage & Handling

StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Early 2 Factor (E2F), Inhibitor, HLM 006474, HLM006474, HLM-006474, inhibit, E2F4 DNA-binding

Similar Products

  • HLM006474 [orb1220004]

    >98% (HPLC)

    353519-63-8

    399.48

    C25H25N3O2

    25 mg, 10 mg, 50 mg, 100 mg, 2 mg, 500 mg, 1 g, 5 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

HLM006474 (orb1308227)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

2 mg
$ 80.00
5 mg
$ 110.00
10 mg
$ 130.00
25 mg
$ 210.00
50 mg
$ 340.00
100 mg
$ 530.00
500 mg
$ 1,130.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry